Contemporary Compounding


September 15, 2017

Progesterone 50 mg/g in VersaBase Cream

This preparation is highly effective at transporting progesterone into and through the skin, surpassing other formulations it was compared against.

August 18, 2017

Chlorhexidine Digluconate 0.05% in Normal Saline Bladder Irrigation

This high-risk formulation for the treatment of bladder infections should be prepared by a pharmacist validated in aseptic compounding.

July 19, 2017

Ethambutol Hydrochloride Compounded Oral Suspension USP (100 mg/mL)

This preparation should be used not as the sole antituberculous drug, but rather in conjunction with one or more others.

June 16, 2017

Didanosine 10 mg/mL Oral Suspension

This preparation is a good example of how pharmacists can be involved in managing patients’ therapy.

May 19, 2017

Topiramate 20 mg/mL Oral Suspension

This agent helps reduce seizure activity and prevent migraines by acting on several chemicals in the brain.

April 21, 2017

Erythromycin 1% Topical Gel

The patient should be counseled that the viscosity of this preparation is temperature dependent.

March 17, 2017

Amitriptyline HCl 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% in Transdermal Pain Base

This preparation may be used topically to treat pain.

February 16, 2017

Furosemide 10 mg/mL Oral Suspension

Furosemide is used to treat edema associated with various disorders, as well as adjunctively to treat acute pulmonary edema.

January 19, 2017

Sucralfate 200 mg/mL and Nystatin 20,000 U/mL Oral Suspension

This preparation may be used in the treatment of ulcerations, erosions, and esophageal infections.

December 16, 2016

Famotidine 8 mg/mL Oral Liquid

This formulation may be used to treat heartburn in patients who cannot swallow tablets or take the commercial product.